News & Events
1Cell.Ai, Formerly OneCell Diagnostics, Launches OncoIncytes Integrating Multi-Modal Data for Precision Oncology
AI-powered precision oncology leader to enhance early-stage clinical studies with the introduction of next-generation technology Foster City, CA. & Mumbai, India (April 22, 2025) – OneCell Diagnostics today announced its launch of OncoIncytes, a comprehensive
Single-Cell Genomics Reveals Resistance Signatures in Colorectal Cancer
Presented at ESMO Congress 2024 – Barcelona, Spain This abstract highlights how true single-circulating tumor cell (CTC) genomics can identify enriched therapy-resistance signatures in advanced colorectal cancer patients. The findings underscore the potential of single-cell
1Cell.Ai Featured in the Journal of Liquid Biopsy
Advancing the Science of ctDNA and CTC-Based Diagnostics Across Cancer Types We’re proud to be featured in five recent publications in the Journal of Liquid Biopsy, the official journal of the International Society of Liquid
Join Us at AACR – April 25-30, 2025
Discover how 1Cell.Ai is advancing precision oncology at the intersection of science and technology Our team is leading the way with AI-powered, single cell multi-omic solutions designed to help in patient selection, therapy monitoring and
Join Us: Europe Launch Dinner Reception
Celebrating the Launch of 1Cell.Ai in Europe You’re invited to an exclusive evening of connection, conversation, and innovation as we officially introduce 1Cell.Ai to the European oncology community. Join us for a private dinner reception
